TNK2 and melanoma: Non-canonical upstream activation of AR in melanoma is an important consideration for future studies of androgen- and AR-regulated melanomagenesis, as independent of its canonical ligand DHT, AR is known to be phosphorylated and activated by other factors (e.g., AKT, HER2, and ACK1 kinases) in prostate cancers77–80.